SGN-1 by Guangzhou Huajin Pharmaceutical Technology for Ovarian Cancer: Likelihood of Approval

SGN-1 is under clinical development by Guangzhou Huajin Pharmaceutical Technology and currently in Phase II for Ovarian Cancer.

Ultra-processed foods raise chronic kidney disease risk, study shows

Consuming ultra-processed foods is linked to an 18% increased risk of chronic kidney disease, with every 10% rise in UPF intake energy contributing to a

April 2, 2024

NPs Have the Best Job in Healthcare

Being a nurse practitioner (NP) is the best job in healthcare, and the physician assistant (PA) is a close second, according to U.S. News &

January 11, 2024

Opinion | The Administrator on Big Changes in CMS

Emily Hutto is an Associate Video Producer & Editor for MedPage Today. She is based in Manhattan. In this exclusive video interview, Jeremy Faust, MD,

October 28, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.